| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | Director | Common Stock | 18,404 | $137,910 | $7.49 | 02 Apr 2025 | By Revocable Living Trust |
| Harpoon Therapeutics, Inc. | Director | Common Stock | 16,456 | $133,294 | $8.10 | 01 Apr 2023 | Direct |
| Harpoon Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 28,571 | $39,999 | $1.40 | 22 Jun 2022 | Direct |
| Personalis, Inc. | Director | Common Stock | 13,506 | $19,854 | $1.47 | 17 May 2022 | Direct |
| Personalis, Inc. | Director | Stock Option (right to buy) | 40,000 | 17 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | 01 Apr 2025 | 2 | +$129,544 | 4 | Director | 03 Apr 2025, 18:05 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 16:28 |
| ALMS | ALUMIS INC. | 27 Jun 2024 | 0 | $0 | 3 | Director | 27 Jun 2024, 18:40 |
| PSNL | Personalis, Inc. | 17 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 18:32 |
| SLRN | ACELYRIN, Inc. | 04 May 2023 | 0 | $0 | 3 | Director | 04 May 2023, 19:40 |
| /report/000120919123022796-colowick-alan-2023-04-01 | Harpoon Therapeutics, Inc. | 01 Apr 2023 | 1 | $0 | 4 | Director | 04 Apr 2023, 17:03 |
| /report/000120919122039324-colowick-alan-2022-06-22 | Harpoon Therapeutics, Inc. | 22 Jun 2022 | 2 | +$39,999 | 4 | Director | 24 Jun 2022, 18:43 |
| PSNL | Personalis, Inc. | 17 May 2022 | 2 | $0 | 4 | Director | 19 May 2022, 19:11 |
| PSNL | Personalis, Inc. | 14 May 2021 | 2 | $0 | 4 | Director | 18 May 2021, 16:22 |
| /report/000120919121032979-colowick-alan-2021-05-04-restatement | Harpoon Therapeutics, Inc. | 04 May 2021 | 0 | $0 | 4/A | Director | 14 May 2021, 20:14 |